Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,713	1,960	1,829	1,318	1,260	985
Market Cap Growth	-9.26%	7.12%	38.81%	4.57%	27.92%	-14.60%
Enterprise Value	2,276	2,445	2,240	1,629	1,521	1,202
Last Close Price	705.20	815.42	760.13	546.57	521.71	407.85

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	309.93	369.08	188.91	144.98	156.37	-
PS Ratio	10.74	8.50	8.34	6.65	6.96	9.95
PB Ratio	47.87	60.61	62.17	56.46	23.92	21.97
P/TBV Ratio	47.87	60.61	62.17	56.46	23.92	21.97
P/OCF Ratio	-	90.16	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
EV/Sales Ratio	14.31	10.61	10.22	8.22	8.40	12.14
EV/EBITDA Ratio	254.65	196.29	122.73	80.79	77.41	-
EV/EBIT Ratio	-	330.94	180.50	123.64	102.35	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Debt / Equity Ratio	18.68	19.76	0.03	16.82	6.55	5.35
Debt / EBITDA Ratio	74.58	49.53	0.05	18.95	16.49	-
Net Debt / Equity Ratio	15.91	15.66	-1.08	15.59	6.22	5.01
Net Debt / EBITDA Ratio	66.20	40.65	-1.75	18.05	16.70	-134.45
Net Debt / FCF Ratio	-30.56	-245.76	0.47	-10.30	-4.39	-41.23
Asset Turnover	0.21	0.35	0.40	0.39	0.39	0.23
Inventory Turnover	0.36	0.55	0.49	0.49	0.54	0.40
Quick Ratio	0.44	0.47	0.38	0.34	0.29	0.29
Current Ratio	0.85	0.83	0.91	0.88	0.92	0.87
Return on Equity (ROE)	16.36%	17.19%	36.70%	23.91%	16.53%	-25.34%
Return on Assets (ROA)	0.34%	0.70%	1.41%	1.62%	2.01%	-1.07%
Return on Invested Capital (ROIC)	0.50%	1.00%	-	2.92%	3.60%	-2.68%
Return on Capital Employed (ROCE)	10.40%	20.30%	36.30%	44.70%	24.80%	-13.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Earnings Yield	0.32%	0.27%	0.53%	0.69%	0.64%	-1.32%
FCF Yield	-1.09%	-0.10%	-3.72%	-2.68%	-5.93%	-0.55%
Dividend Yield	0.14%	0.12%	0.13%	0.27%	0.19%	-
Payout Ratio	39.37%	44.23%	34.91%	11.00%	18.61%	-
Total Shareholder Return	0.14%	0.12%	0.13%	0.27%	0.19%	-

Data Source: S&P Global Market Intelligence Last updated: Jun 1, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error